Nagai, N.; Ogata, F.; Deguchi, S.; Fushiki, A.; Daimyo, S.; Otake, H.; Kawasaki, N.
Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles. Pharmaceutics 2022, 14, 2431.
https://doi.org/10.3390/pharmaceutics14112431
AMA Style
Nagai N, Ogata F, Deguchi S, Fushiki A, Daimyo S, Otake H, Kawasaki N.
Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles. Pharmaceutics. 2022; 14(11):2431.
https://doi.org/10.3390/pharmaceutics14112431
Chicago/Turabian Style
Nagai, Noriaki, Fumihiko Ogata, Saori Deguchi, Aoi Fushiki, Saki Daimyo, Hiroko Otake, and Naohito Kawasaki.
2022. "Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles" Pharmaceutics 14, no. 11: 2431.
https://doi.org/10.3390/pharmaceutics14112431
APA Style
Nagai, N., Ogata, F., Deguchi, S., Fushiki, A., Daimyo, S., Otake, H., & Kawasaki, N.
(2022). Design of a Transdermal Sustained Release Formulation Based on Water-Soluble Ointment Incorporating Tulobuterol Nanoparticles. Pharmaceutics, 14(11), 2431.
https://doi.org/10.3390/pharmaceutics14112431